NDC Code(s) : 61786-083-02
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
ziprasidone hydrochlorideziprasidone hydrochloride CAPSULE | ||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: ziprasidone hydrochloride
GENERIC: ziprasidone hydrochloride
DOSAGE: CAPSULE
ADMINSTRATION: ORAL
NDC: 61786-083-02
COLOR: yellow
SHAPE: CAPSULE
SCORE: No score
SIZE: 14 mm
IMPRINT: SZ;656
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
- ZIPRASIDONE HYDROCHLORIDE 20mg in 1
INACTIVE INGREDIENT(S):
- CALCIUM SILICATE
- FERROSOFERRIC OXIDE
- POTASSIUM HYDROXIDE
- TITANIUM DIOXIDE
- AMMONIA
- PROPYLENE GLYCOL
- SHELLAC
- SODIUM LAURYL SULFATE
- ANHYDROUS LACTOSE
- CARBOXYMETHYLCELLULOSE
- CITRIC ACID MONOHYDRATE
- MAGNESIUM STEARATE
- FD&C BLUE NO. 2
- GELATIN
- FERRIC OXIDE YELLOW
- STARCH, CORN